Morning Buzz: Heron Therapeutics (HRTX), Goldman (GS), Yahoo (YHOO), Harley-Davidson (HOG)

Shares of Heron Therapeutics, Inc. (HRTX) are higher by 17.50% to $25.25 in pre-market trading on Tuesday after the company announced that the FDA has indicated that there are no substantive deficiencies in the New Drug Application for SUSTOL and has begun labeling discussions with the company.

Goldman Sachs Group, Inc. (GS) shares are down $1.54 to $157.48 in pre-market trading Tuesday after the company reported its first quarter earnings results.

The New York City-based firm posted earnings of $2.68 per share on revenues of $6.34 billion, down 40.3% from a year ago. Analysts were expecting EPS of $2.50 on revenues of $6.52 billion.

Yahoo (YHOO) received offers for its assets from Yellow Pages parent YP Holdings, private-equity firm TPG, and Verizon (VZ), according to a Bloomberg report. Yahoo had set Monday as the deadline for initial bids.

In other Yahoo news this morning, NY Post discusses that Yahoo might see painful revenue drops in its core search and display-ad businesses this year.

Yahoo shares were little changed at $36.50 at Tuesday’s pre-market trading in New York.

Harley-Davidson, Inc. (HOG) reported first quarter EPS of $1.36 before the opening bell Tuesday, compared to the consensus estimate of $1.30. Revenues increased 4.4% from last year to $1.58 billion. Analysts expected revenues of $1.50 billion. The stock is currently up $0.24 to $47.19.

Be the first to comment

Leave a Reply

Your email address will not be published.


*